These findings demonstrate that metal ion leaching presents a substantial challenge to the process consistency of mAb. We have proposed a series of targeted and practical solutions to address the issue of "equipment and material leaching" during the production of mAb glycosylation amplification.
Liu et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: